BRAFV600E Mutation and Papillary Thyroid Cancer—In Reply

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.2013.8598
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Medical Association (AMA)

Related search

The Prevalence and Prognostic Value of BRAFV600E Mutation in Papillary Thyroid Cancer

International Journal of Human and Health Sciences (IJHHS)
2019English

Clinical Implication of the BRAFV600E Mutation in Papillary Thyroid Carcinoma

World Journal of Surgical Oncology
SurgeryOncology
2013English

Vemurafenib for BRAFV600E-positive Metastatic Papillary Thyroid Cancer – Authors' Response

The Lancet Oncology
Oncology
2016English

IL-12 Immunotherapy of BrafV600E-induced Papillary Thyroid Cancer in a Mouse Model

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2015English

Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2010English

Recurrent Papillary Craniopharyngioma With BRAFV600E Mutation Treated With Neoadjuvant-Targeted Therapy

Acta Neurochirurgica
SurgeryNeurology
2017English

Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

BRAFV600E and Microenvironment in Thyroid Cancer: A Functional Link to Drive Cancer Progression

Cancer Research
Cancer ResearchOncology
2011English

Papillary Thyroid Cancer in Three Children

Pediatric Endocrinology, Diabetes and Metabolism
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy